Sante Health Ventures
SelectiveFiled to raiseAustin, TXBiotechnology, Pharmaceuticals, HealthcareLast fund filed December 2024
3 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| SHV Opportunities A | December 2024 | $15M | $15M | 3 |
| Sante Health Ventures V | April 2024 | $300M | $258M | 63 |
| Sante Health Ventures IVFiled to raise in 2021, with no closing reported yet. | 2021 | $250M | $0 | 0 |
| Sante Health Ventures IIIFiled to raise in 2018, with no closing reported yet. | 2018 | $200M | $0 | 0 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
4 partners are named across this firm’s filings, 3 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Douglas French | Slowing | Healthcare services, Medical devices | 5 | 1 |
Classified sectors of Sante Health Ventures’s own portfolio companies, based on 18 with a verified or cited source.
| Firm | Shared boards | Companies |
|---|---|---|
| Solas BioVentures | 2 | BIOSTABLE SCIENCE & ENGINEERING, CryOSA |
| LRVHealth | 1 | Reimagine Care |
| NEA | 1 | Lumos Pharma |
| Rivervest | 1 |
| Sante Health Ventures I Annex FundFiled to raise in 2015, with no closing reported yet. |
| 2015 |
| $15M |
| $0 |
| 0 |
| Sante Health Ventures II | February 2011 | $139M | $139M | 17 |
| Joe Cunningham | Slowing | Biotech & pharma, Medical devices, Aerospace & defense | 8 | 1 |
| Eadie JamesNot on the current fund | Quiet | Biotech & pharma | 1 | 0 |
| Kevin Lalande | Quiet | Biotech & pharma, Digital health, Healthcare services | 8 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Sante Health Ventures’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Lyric Pharmaceuticals |
| Versant Venture Capital | 1 | ChanRx |
A shared board seat: a company where filings name a Sante Health Ventures partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.